Journal of the American Society of Hypertension
Volume 2, Issue 1 , Pages 28-38 , January 2008

Basis for use of central blood pressure measurement in office clinical practice

  • Michael F. O’Rourke, MD, DSc

      Affiliations

    • Dr. Michael F. O’Rourke is a founding director of AtCor Medical (maker of the SphygmoCor® device).
    • Corresponding Author InformationCorresponding author: Michael F. O’Rourke, MD, DSc, Suite 810, St. Vincent’s Clinic, 438 Victoria Street, Darlinghurst, NSW 2010, Australia. Tel: +61 2 8382 6874; fax: +61 2 8382 6875.
    • ,
  • Audrey Adji, MB, MBiomedE

Received 15 March 2007 ,Accepted 23 August 2007.

References 

  1. Mahomed FA. The physiology and clinical use of the sphymograph. Medical Time Gazette. 1872;1:62–64128–30, 220–22, 250–51, 340–42, 427–29, 569–71; 2:143–45, 1872–73.
  2. Bright R. Reports of medical cases selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy. London, England: Longmans; 1827;
  3. Gull WW. Bright’s disease with contracted kidney (arterio–capillary fibrosis). BMJ. 1872;II:692
  4. Gull WW, Sutton HG. On the pathology of the morbid state commonly called chronic Bright’s disease “arteriocapillary fibrosis”. Med Chir Trans. 1872;273–326
  5. Broadbent WH. The pulse. London, England: Cassell; 1890;
  6. Mackenzie J. The study of the pulse: arterial, venous and hepatic, and of the movements of the heart. Edinburgh, England: Young J. Pentland; 1902;
  7. Agabiti-Rosei E, Mancia G, O’Rourke M, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50:154–160
  8. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure–lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation. 2006;113:1213–1225
  9. London GM, Asmar RG, O’Rourke MF, Safar ME REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low–dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92–99
  10. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Tauqeer A, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197–203
  11. Pauca AL, Kon ND, O’Rourke MF. The second peak of the radial artery pressure wave represents aortic systolic pressure in hypertensive and elderly patients. Br J Anaesth. 2004;92:651–657
  12. Takazawa K, Hideyuki K, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial pulse wave. Hypertens Res. 2007;30:219–228
  13. van Bortel LM, Segers P. Direct measurement of local arterial stiffness and pulse pressure. In:  Safar ME,  O’Rourke MF editor. Arterial stiffness in hypertension. Edinburgh, England: Elsevier; 2006;p. 35–52
  14. Adji A, Hirata K, Hoegler S, O’Rourke MF. Noninvasive pulse waveform analysis in clinical trials: similarity of two methods for calculating aortic systolic pressure. Am J Hypertens. 2007;20:917–922
  15. O’Rourke MF, Seward JB. Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov. Mayo Clin Proc. 2006;81:1057–1068
  16. O’Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2006;50:1–13
  17. Laurent S, Cockcroft JR, van Bortel L, Boutouyrie P, Giannattassio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605
  18. Kelly RP, Hayward CS, Ganis J, Daley J, Avolio AP, O’Rourke MF. Noninvasive registration of the arterial pressure pulse waveform using high–fidelity applanation tonometry. J Vasc Med Biol. 1989;1:142–149
  19. Chen C–H, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation. 1997;95:1827–1836
  20. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932–937
  21. Gallagher D, Adji A, O’Rourke MF. Validation of the transfer function technique for generating central from peripheral upper limb pressure waveform. Am J Hypertens. 2004;17:1059–1067
  22. O’Rourke MF, Pauca AL. Augmentation of the aortic and central arterial pressure waveform. Blood Press Monit. 2004;9:179–185
  23. Adji A, Hirata K, O’Rourke MF. Clinical use of indices determined noninvasively from the radial and carotid pressure waveforms. Blood Press Monit. 2006;11:215–221
  24. Hirata K, Yaginuma T, O’Rourke MF, Kawakami M. Age–related changes in carotid artery flow and pressure pulses. Stroke. 2006;37:2552–2556
  25. van Bortel LM, Balkestein E, van der Heijden–Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, et al. Noninvasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo–tracking. J Hypertens. 2001;19:1037–1044
  26. Kelly RP, Karamanoglu M, Gibbs H, Avolio AP, O’Rourke MF. Noninvasive carotid pressure wave registration as an indicator of ascending aortic pressure. J Vasc Med Biol. 1989;1:241–247
  27. O’Rourke MF, Pauca AL, Jiang X-J. Pulse wave analysis. Br J Clin Pharmacol. 2001;51:507–522
  28. Adji A, O’Rourke MF. Determination of central aortic systolic and pulse pressure from the radial artery pressure waveform. Blood Press Monit. 2004;9:115–121
  29. Kroeker E, Wood E. Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res. 1955;3:623–632
  30. In:  Nichols WW,  O’Rourke MF editor. McDonald’s blood flow in arteries. 5th ed.. London, England: Hodder Arnold; 2005;p. 464–502
  31. McEniery CM, Yasmin , Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo–Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753–1760
  32. Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension. 2001;38:1461–1466
  33. O’Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic hypertension in youth. Vasc Med. 2000;5:141–145
  34. Mahmud A, Feely J. Spurious systolic hypertension of youth: fit young men with elastic arteries. Am J Hypertens. 2003;16:229–232
  35. Hulsen HT, Nijdam M-E, Bos W-J, Uiterwaal CS, Oren A, Grobbee DE, et al. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and lower central pressure and its determinants. J Hypertens. 2006;24:1027–1032
  36. McEniery CM, Yasmin , Wallace S, Maki–Petaja K, McDonnell B, Sharman JE, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension. 2005;46:221–226
  37. Pickering TG. Isolated systolic hypertension in the young. J Clin Hypertens. 2004;6:47–48
  38. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. The relation of blood pressure to coronary heart disease risk as a function of age: the Framingham Heart Study. J Am Coll Cardiol. 2000;35(Suppl 1):A291–A292
  39. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? (the Framingham Heart Study). Circulation. 2001;103:1245–1249
  40. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required vs atenolol adding bendroflumethiazide as required, in the Anglo–Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT–BPLA): a multicentre randomized controlled trial. Lancet. 2005;366:895–906
  41. Hypertension: management of hypertension in adults in primary care. London: United Kingdom National Institute for Health and Clinical Excellence; 2006;
  42. Messerli F, Ventura H, Amodeo C. Osler’s maneuver and pseudohypertension. N Engl J Med. 1985;312:1548–1551
  43. French Society of Hypertension/International Society of Hypertension. In:  Postel–Vinay N editors. A century of arterial hypertension: 1896–1996. Chichester: John Wiley & Sons; 1996;p. 31–48
  44. In:  Safar ME,  O’Rourke MF editor. Arterial stiffness in hypertension. London, England: Elsevier; 2006;p. 379–398and 503–16
  45. Lewis T. The factors influencing the prominence of the dicrotic wave. J Physiol. 1906;34:414–429
  46. Westerhof N, O’Rourke M. Hemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13:943–952
  47. Weissler A, Harris L, White G. Left ventricular ejection time index in man. J Appl Physiol. 1963;18:919–923
  48. O’Rourke MF, Lei J. Separation of systolic from diastolic dysfunction as a cause of cardiac failure by analysis of the arterial pulse wave. Aust NZ J Med. 1997;28:114
  49. Uebaba K, O’Rourke M, Sindone A, Keogh A, Siswanto B, MacDonald P. Arterial pulse wave analysis for the assessment of cardiac failure: value of noninvasive applanation tonometry of radial artery. Jpn J Appl Physiol. 2002;32:147–157
  50. Weber T, Auer J, O’Rourke M, Punzengruber C, Kvas E, Eber B. Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction. Heart. 2006;92:1616–1622
  51. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim H-W, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:2993–2999
  52. Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C. Relation between diastolic perfusion time and coronary artery stenosis during stress–induced myocardial ischemia. Circulation. 1995;92:342–347
  53. Boden W, O’Rourke R, Teo K, Hartigan P, Maron D, Kostuk W, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516
  54. Hoffman J, Buckberg G. The myocardial supply:demand ratio: a critical review. Am J Cardiol. 1978;41:327–332
  55. Hoffman J. Maximal coronary flow and the concept of coronary vascular reserve. Circulation. 1984;70:153–159

PII: S1933-1711(07)00172-6

doi: 10.1016/j.jash.2007.08.006

Journal of the American Society of Hypertension
Volume 2, Issue 1 , Pages 28-38 , January 2008

Article Tools

* Image Usage & Resolution